Ben Dach is an associate in Quinn Emanuel’s New York office. He is a life sciences patent attorney with a focus on patent litigation in the chemical, biological, and pharmaceutical sciences.
Before joining the firm in 2018, Ben worked six years at an intellectual property boutique where he focused on patent litigation, prosecution, counseling, opinion work, and patent strategy in a broad range of technologies. He has experience in all stages of patent litigation, including pre-suit investigation, fact and expert discovery, trial, post-trial, and appeals. Ben has represented innovative brand name pharmaceutical companies in complex Hatch-Waxman litigations against multiple defendants.
His practice also includes performing diligence on IP portfolios regarding the patentability of inventions, the validity of patents, and the freedom-to-operate new technologies.
He is part of Quinn Emanuel’s Cannabis Litigation Practice Group. His writings have been published by JDSupra and in Quinn Emanuel’s Cannabis Litigation Practice Group’s client alerts. He has also been a cannabis law panel speaker.
Ben received his J.D. from Fordham Law School. As a graduate researcher, Ben earned a Ph.D in Chemistry from Columbia University in 2012. And he received a B.A. in Chemistry from Yeshiva University in 2007.
- Fordham University School of Law
- (J.D., 2017)
- Dean’s List
- Dean’s List
- Columbia University Graduate School of Arts and Sciences
- (Ph.D., Chemistry, 2012)
- (M.Phil., Chemistry, 2011)
- (M.A., Chemistry, 2008)
- Yeshiva University
- (B.A., magna cum laude, Chemistry and Pre-Engineering, 2007)